, triggers a transcriptional program that includes the production of type I IFNs. These antiviral cytokines signal in both autocrine and paracrine fashion through the JAK-STAT pathway leading to additional transcription events involving the differential expression of many hundreds of genes. The antiviral state produced by this extensive genetic reprogramming involves a core set of genes as well as pathogenspecific components (1).The DC response to individual pathogens involves multiple signals that must be integrated to initiate an appropriate immune response. Pathogenic viruses attempt to subvert normal immune function through the expression of IFN antagonists (2, 3). For example, IFN regulatory factor (IRF) 3 activation and IFN-b expression are blocked by the NS1 protein of influenza (4). Unraveling the impact of these immune antagonists would be aided by a detailed understanding of the genetic regulatory network that operates during an uninhibited antiviral response. This knowledge is lacking because previous human studies have used viruses that interfere with the immune response (4-6). One fundamental unresolved question is to what extent the antiviral response is a single interconnected transcriptional cascade (convergent architecture) or a combination of transcriptional events operating independently in reaction to the multiple signals that arise following viral insult (parallel architecture). Newcastle disease virus (NDV) infection of human DCs provides an ideal system to define the uninhibited regulatory network (7,8). NDV is an avian virus that is able to stimulate innate immunity and DC maturation, but lacks the ability to evade the human interferon response (9). By focusing on NDV, we can accurately depict the baseline network of transcription factor (TF) interactions that underlie a broad range of immune responses. Through comparative studies, this network will enable detailed analysis of other infections and greatly improve our understanding of the control mechanisms in antiviral immunity and the myriad ways through which pathogenic viruses subvert normal immune function.Systems biology methods combined with high-throughput experimental technologies are providing new insights into virus-host interactions (10, 11). Genome-wide transcriptional profiling has suggested that the DC antiviral response is characterized by temporal waves of gene activation, which may be controlled by different combinations of transcriptional regulators (1). Potential regulators can be implicated using direct approaches, such as differential expression of the TF mRNA (1) -regulatory motifs (12, 13). These methods typically provide a static view of the network. Other computational methods have been proposed to identify TFs driving time-dependent changes in expression, but these do not explicitly account for the regulation of the TF itself (14, 15). The most common approaches are based on the hypothesis that genes sharing a similar temporal profile are regulated by common TFs (16). In mammals, a variety of posttranscriptional ...